{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:59:49Z","timestamp":1783763989238,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":605,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jmii.2012.09.001","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T21:52:29Z","timestamp":1349992349000},"page":"197-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections"],"prefix":"10.1016","volume":"47","author":[{"given":"Yi-Hui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Pin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2012.09.001_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2012.09.001_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2011.05.015","article-title":"Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region","volume":"6","author":"Hsueh","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2012.09.001_bib3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s10096-011-1457-x","article-title":"The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens","volume":"31","author":"Chen","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2012.09.001_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jmii.2011.01.015","article-title":"Consensus statement on the role of fluoroquinolones in the management of urinary tract infections","volume":"44","author":"Hsueh","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2012.09.001_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00120-011-2512-z","article-title":"National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients","volume":"50","author":"Wagenlehner","year":"2011","journal-title":"Urologe A"},{"key":"10.1016\/j.jmii.2012.09.001_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10096-011-1322-y","article-title":"Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection","volume":"31","author":"Smithson","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2012.09.001_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jac\/dkq465","article-title":"Risk factors for fluoroquinolone- resistant Escherichia coli in adults with community-onset febrile urinary tract infection","volume":"66","author":"van der Starre","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2012.09.001_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmicb.2012.00009","article-title":"Extraintestinal pathogenic Escherichia coli: A combination of virulence with antibiotic resistance","volume":"3","author":"Pitout","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2012.09.001_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","article-title":"Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact","volume":"23","author":"Oteo","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jmii.2012.09.001_bib10","first-page":"271","article-title":"Guidelines for antimicrobial therapy of urinary tract infections in Taiwan","volume":"33","year":"2000","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2012.09.001_bib11","first-page":"328","article-title":"Childhood urinary tract infection: a clinical analysis of 597 cases","volume":"45","author":"Wu","year":"2004","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.jmii.2012.09.001_bib12","first-page":"56","article-title":"Is combination antimicrobial therapy required for urinary tract infection in children?","volume":"36","author":"Lu","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2012.09.001_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.amjopharm.2011.07.002","article-title":"Urinary tract infections in the elderly population","volume":"9","author":"Matthews","year":"2011","journal-title":"Am J Geriatr Pharmacother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821200206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821200206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:18:06Z","timestamp":1761657486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411821200206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S168411821200206X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2012.09.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2012.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}